RAB9A (Ras-related Protein Rab-9A): A Comprehensive Research Report

Introduction and Overview

RAB9A encodes Ras-related protein Rab-9A, a small GTPase belonging to the Rab family within the Ras superfamily of small GTP-binding proteins. The human RAB9A gene is located on chromosome Xp22.2 and produces a 201-amino acid protein that is highly conserved across mammals [lombardi-1993-rab9-discovery-abstract]. RAB9A functions as a molecular switch that cycles between an active GTP-bound state and an inactive GDP-bound state, a property characteristic of all Rab GTPases that allows them to regulate membrane trafficking events with precise spatial and temporal control [wittmann-2004-rab9-structure-abstract].

The primary and best-characterized function of RAB9A is the regulation of retrograde transport from late endosomes to the trans-Golgi network (TGN). This transport pathway is essential for recycling mannose 6-phosphate receptors (MPRs), which are critical for the proper delivery of lysosomal hydrolases to lysosomes [lombardi-1993-rab9-discovery-abstract]. Without functional RAB9A, MPRs become trapped in the endosomal system and are eventually degraded, leading to defects in lysosomal enzyme delivery and subsequent cellular dysfunction [ganley-2004-rab9-endosome-size-abstract]. Beyond its canonical role in MPR trafficking, RAB9A has been implicated in alternative autophagy pathways, viral replication, and has emerged as a potential therapeutic target for lysosomal storage disorders such as Niemann-Pick type C disease [nishida-2009-alternative-autophagy-abstract][murray-2005-rab9-virus-abstract][kaptzan-2009-rab9-transgenic-npc-abstract].

Molecular Structure and GTPase Mechanism

Structural Features

The crystal structure of human RAB9A has been solved at 1.77 Å resolution (PDB: 1WMS), revealing the characteristic fold of Ras superfamily GTPases [wittmann-2004-rab9-structure-abstract]. The protein adopts a nucleotide-binding fold consisting of a six-stranded β-sheet surrounded by five α-helices, with the guanine nucleotide binding site located in a central pocket. Like other Rab proteins, RAB9A contains two "switch" regions (switch I and switch II) that undergo conformational changes upon GTP binding and hydrolysis. These switch regions are the primary determinants of effector binding specificity and are disordered in the GDP-bound state but become ordered upon GTP binding [wittmann-2004-rab9-structure-abstract].

An unusual feature revealed by crystallography is that RAB9A can form dimers through an intermolecular β-sheet that buries the switch I regions. When complexed with strontium rather than magnesium, the GDP-bound form displays conformations resembling the active GTP-bound state, including a hydrophobic tetrad that serves as an effector-discriminating epitope [wittmann-2004-rab9-structure-abstract]. This structural finding suggests that membrane-bound pools of RAB9A-GDP may exist in a pre-activated conformation that facilitates rapid engagement of effectors upon nucleotide exchange.

The GTPase Cycle and Membrane Association

RAB9A, like all Rab proteins, undergoes post-translational modification by geranylgeranylation at its C-terminal cysteine residues, which is essential for membrane association [lombardi-1993-rab9-discovery-abstract]. The protein cycles between cytosolic and membrane-bound pools, with this cycling regulated by guanine nucleotide dissociation inhibitor (GDI). In the cytosol, RAB9A exists as a complex with GDI, which binds the prenyl groups and maintains the protein in a soluble state [dirac-svejstrup-1994-gdi-rab9-abstract].

The Rab9-GDI complex represents a functional pool of RAB9A that can be delivered to late endosomal membranes. GDI not only solubilizes the protein but also contributes to targeting selectivity; experiments demonstrated that serum albumin could solubilize prenylated RAB9A, but unlike GDI-mediated delivery, this led to indiscriminate membrane association [dirac-svejstrup-1994-gdi-rab9-abstract]. RAB9A binds GDI with particularly high affinity (Kd ≤23 nM), which initially led researchers to predict the existence of a dedicated GDI displacement factor (GDF) that would catalyze the release of RAB9A from GDI at target membranes [dirac-svejstrup-1997-gdf-abstract]. This GDF was subsequently identified as Yip3/PRA1, an integral membrane protein localized to the Golgi and late endosomes that acts catalytically to dissociate endosomal Rab-GDI complexes [dirac-svejstrup-1997-gdf-abstract]. Importantly, GDF is not a guanine nucleotide exchange factor; it does not influence nucleotide exchange rates but rather releases Rabs from GDI, permitting them to exchange nucleotide at their intrinsic rates. In vivo, depletion of PRA1/Yip3 reduces membrane-associated RAB9A with a corresponding increase in the cytosolic pool. Following GDI displacement, guanine nucleotide exchange factors (GEFs) catalyze the exchange of GDP for GTP, activating RAB9A and enabling effector recruitment. The intrinsic GTPase activity of RAB9A, potentially stimulated by GTPase-activating proteins (GAPs), hydrolyzes GTP to GDP, returning the protein to its inactive state and enabling GDI-mediated extraction from membranes for another round of cycling.

Subcellular Localization

RAB9A localizes primarily to late endosomes, where it occupies a distinct membrane domain that is spatially segregated from the related RAB7 GTPase [barbero-2002-rab9-visualization-abstract]. Live-cell imaging studies using fluorescent protein fusions have demonstrated that while both RAB9A and RAB7 are present on late endosomes, they occupy non-overlapping membrane domains. Importantly, cation-independent mannose 6-phosphate receptors (CI-MPRs) are enriched in the RAB9A-positive domains relative to RAB7-positive regions, consistent with RAB9A's role in MPR recycling [barbero-2002-rab9-visualization-abstract].

Videomicroscopy of living cells has revealed that small RAB9A-positive vesicles bud from late endosomes and move toward the Golgi complex, eventually fusing with the trans-Golgi network [barbero-2002-rab9-visualization-abstract]. This was the first direct visualization of RAB9A-mediated transport and confirmed that this pathway uses vesicular rather than tubular intermediates. RAB9A appears to remain associated with transport vesicles through the docking process and is rapidly removed either concomitant with or immediately after membrane fusion.

Effector Proteins and Molecular Mechanism of MPR Transport

The transport of MPRs from late endosomes to the TGN requires the coordinated action of RAB9A with multiple effector proteins. Five well-characterized RAB9A effectors have been identified: TIP47 (tail-interacting protein of 47 kDa), p40, GCC185, RhoBTB3, and Nde1/NDEL1. Each plays a distinct role in the transport process.

TIP47: Cargo Selection and Recruitment

TIP47 was identified as a cytosolic protein that recognizes the cytoplasmic domains of both cation-dependent and cation-independent mannose 6-phosphate receptors [carroll-2001-tip47-rab9-abstract]. The protein binds directly to RAB9A-GTP through a binding site that includes residues 161-169, which are essential for the interaction [hanna-2002-tip47-binding-abstract]. Critically, RAB9A binding enhances the affinity of TIP47 for MPR cytoplasmic domains, effectively coupling cargo selection to the presence of active RAB9A on membranes [carroll-2001-tip47-rab9-abstract].

The TIP47-RAB9A interaction exemplifies a elegant mechanism for cargo sorting: RAB9A-GTP recruits TIP47 from the cytosol to late endosomal membranes, where the enhanced affinity for MPR tails allows TIP47 to concentrate MPRs into nascent transport vesicles. A functional RAB9A binding site is required for TIP47's ability to stimulate MPR transport in vivo, demonstrating that this interaction is not merely regulatory but essential for cargo capture [carroll-2001-tip47-rab9-abstract]. The interaction between RAB9A and TIP47 is also bidirectionally important: TIP47 binding stabilizes RAB9A on membranes, and in the absence of TIP47, RAB9A becomes destabilized and is more readily extracted by GDI [ganley-2004-rab9-endosome-size-abstract].

p40: Vesicle Docking

The p40 protein was identified through a yeast two-hybrid screen as a novel RAB9A effector that binds preferentially to the GTP-bound form with approximately 4-fold selectivity over the GDP-bound form [diaz-1997-p40-effector-abstract]. Unlike TIP47, p40 does not appear to function in cargo selection but rather acts at a later stage of transport, specifically in vesicle docking at the TGN. p40 is found in both cytosolic and membrane-associated pools, with the membrane fraction co-fractionating with MPR-containing endosomes [diaz-1997-p40-effector-abstract].

Recombinant p40 stimulates the overall extent of endosome-to-TGN transport in cell-free assays, and antibodies against p40 inhibit this transport. The synergistic action of p40 and RAB9A in transport suggests they act together to drive vesicle docking, potentially by catalyzing the assembly of other docking factors on transport vesicle surfaces [diaz-1997-p40-effector-abstract].

GCC185: Vesicle Tethering at the TGN

GCC185 is a member of the golgin family of coiled-coil proteins that are anchored to Golgi membranes and project into the cytoplasm to capture incoming vesicles. GCC185 localizes to the TGN through cooperative interactions with Rab6 and Arl1 GTPases at its C-terminus [reddy-2006-gcc185-abstract]. The protein contains a specific RAB9A binding site in its central coiled-coil domain, and this interaction is important for MPR recycling to the Golgi complex.

Cells depleted of GCC185 accumulate MPRs in RAB9A-positive transport carriers, demonstrating that GCC185 functions as a tethering factor that captures incoming vesicles at the TGN [reddy-2006-gcc185-abstract]. Loss of GCC185 leads to enhanced degradation of MPRs (due to their misrouting to lysosomes) and increased secretion of lysosomal enzymes such as hexosaminidase. The current model proposes that GCC185 is anchored to the TGN through Rab6 and Arl1, and captures RAB9A-decorated transport vesicles via its RAB9A binding domain, bringing them close to the target membrane for subsequent SNARE-mediated fusion [reddy-2006-gcc185-abstract].

RhoBTB3: Vesicle Uncoating

RhoBTB3 represents an atypical member of the Rho GTPase family that, remarkably, functions as an ATPase rather than a GTPase [espinosa-2009-rhobtb3-abstract]. This 69 kDa protein contains an N-terminal Rho-like domain (which binds and hydrolyzes ATP) and a C-terminal BTB domain. RhoBTB3 was identified as a RAB9A effector through yeast two-hybrid screening and localizes to the Golgi complex [espinosa-2009-rhobtb3-abstract].

The ATPase activity of RhoBTB3 is autoinhibited in its basal state, and RAB9A binding relieves this autoinhibition to enable maximal ATP hydrolysis. The proposed function of RhoBTB3 is vesicle uncoating: once RAB9A-positive vesicles arrive at the TGN, RAB9A binding activates RhoBTB3's ATPase, which may drive the removal of TIP47 and other coat proteins from vesicles to permit subsequent SNARE pairing and membrane fusion [espinosa-2009-rhobtb3-abstract]. Depletion of RhoBTB3 disperses MPRs into peripheral RAB9A-positive vesicles, similar to the phenotype seen with GCC185 depletion.

Nde1/NDEL1: Dynein Motor Recruitment

A recent structural and biochemical study identified Nde1 and its paralog NDEL1 as RAB9A effectors that link late endosomes to the cytoplasmic dynein motor complex [zhang-2022-nde1-rab9-dynein-abstract]. Nde1 and NDEL1 are well-known regulators of cytoplasmic dynein that, together with Lis1, control dynein activation and cargo loading. The crystal structure of the RAB9A-GTP-Nde1 complex (PDB: 7E1T) revealed how RAB9A in its active state directly interacts with Nde1's Rab9-binding region [zhang-2022-nde1-rab9-dynein-abstract].

Functional studies demonstrated that RAB9A variants unable to bind Nde1 also failed to associate with dynein, Lis1, and dynactin, establishing that Nde1 is essential for connecting RAB9A-positive late endosomes to the microtubule-based motor machinery. This finding provides a direct molecular explanation for the long-observed requirement for cytoplasmic dynein in RAB9A-mediated retrograde transport [zhang-2022-nde1-rab9-dynein-abstract]. The Nde1/NDEL1 interaction represents the most recently characterized RAB9A effector and completes the model of how RAB9A coordinates both cargo selection (via TIP47) and motor-driven transport (via Nde1/NDEL1) on the same membrane platform.

Additional Transport Components

Beyond the four characterized effectors, the complete molecular machinery for MPR transport includes several additional components. The transport process requires NSF and α-SNAP (the general membrane fusion machinery), as well as a SNARE complex comprising Syntaxin-10, Syntaxin-16, Vti1a, and VAMP3 [itin-1999-mapmodulin-abstract]. Transport is also enhanced by the microtubule cytoskeleton: cytoplasmic dynein, a minus-end-directed motor, facilitates vesicle movement from peripheral late endosomes toward the centrally located Golgi complex. Mapmodulin, a protein that interacts with microtubule-associated proteins, stimulates the initial rate of MPR transport in vitro [itin-1999-mapmodulin-abstract].

Role in Alternative Autophagy

A surprising discovery in 2009 revealed that RAB9A plays an essential role in an alternative autophagy pathway that operates independently of Atg5 and Atg7, proteins previously thought to be indispensable for macroautophagy [nishida-2009-alternative-autophagy-abstract]. This alternative pathway generates autophagosomes through a mechanism fundamentally different from conventional autophagy: rather than using LC3 lipidation (the hallmark of canonical autophagy), autophagosomes form through RAB9A-dependent fusion of isolation membranes with vesicles derived from the trans-Golgi network and late endosomes [nishida-2009-alternative-autophagy-abstract].

In cells lacking Atg5 or Atg7, stress conditions can still induce autophagosome formation and autophagy-mediated protein degradation. GFP-RAB9A colocalizes with autolysosomes in stressed Atg5-deficient cells, and silencing RAB9A reduces the number of autophagic vacuoles while causing accumulation of isolation membranes [nishida-2009-alternative-autophagy-abstract]. This indicates that RAB9A is required for the closure and maturation of autophagosomes in the alternative pathway, likely by mediating membrane fusion events.

The alternative autophagy pathway is not merely an artifact of genetic perturbation but appears to have substantial physiological significance. In vivo studies detected Atg5-independent autophagy in embryonic tissues and during erythroid maturation, where it contributes to mitochondrial clearance during red blood cell differentiation [nishida-2009-alternative-autophagy-abstract]. Both the conventional and alternative autophagy pathways are regulated by Ulk1 and Beclin1, suggesting shared upstream signaling despite divergent membrane sources and molecular machinery.

Subsequent studies have elucidated the molecular mechanism of RAB9A-mediated alternative mitophagy, particularly in the context of cardiac protection during ischemia [saito-2019-rab9-mitophagy-heart-abstract]. This pathway involves a protein complex consisting of Ulk1, RAB9A, receptor-interacting serine/threonine protein kinase 1 (Rip1), and dynamin-related protein 1 (Drp1). Ulk1 directly phosphorylates RAB9A at serine 179, and phosphorylated RAB9A then serves as a platform for the assembly of a Rip1-Drp1 complex. Rip1 subsequently phosphorylates Drp1 at serine 616, which marks mitochondria for sequestration by RAB9A-associated membranes derived from the trans-Golgi network [saito-2019-rab9-mitophagy-heart-abstract]. This pathway plays an essential role in protecting the heart against ischemia and represents a major mechanism by which cells eliminate damaged mitochondria under energy stress conditions.

Relevance to Human Disease

Niemann-Pick Type C Disease

Niemann-Pick type C (NPC) disease is an autosomal recessive lysosomal storage disorder characterized by massive accumulation of cholesterol and glycosphingolipids in late endosomes and lysosomes, leading to progressive neurodegeneration [ganley-2006-cholesterol-npc-abstract]. The disease is caused by mutations in NPC1 or NPC2 genes, which encode proteins involved in cholesterol efflux from lysosomes. RAB9A has emerged as a critical player in NPC pathophysiology and a potential therapeutic target.

Studies have shown that RAB9A levels are elevated 1.8-fold in NPC cells compared to wild-type cells, with the protein's half-life increased 1.6-fold [ganley-2006-cholesterol-npc-abstract]. This accumulation reflects impaired protein turnover rather than increased synthesis. Mechanistically, cholesterol appears to directly stabilize RAB9A on endosomal membranes, reducing its capacity for GDI-mediated extraction. Liposomes loaded with prenylated RAB9A showed decreased extractability with increasing cholesterol content, confirming a direct effect of cholesterol on RAB9A membrane association [ganley-2006-cholesterol-npc-abstract].

The sequestration of RAB9A in NPC cells has functional consequences: MPR trafficking is disrupted, leading to receptor degradation in lysosomes and impaired delivery of lysosomal hydrolases. This defect can be rescued by RAB9A overexpression, suggesting that while RAB9A is sequestered, it is not completely inactivated [ganley-2006-cholesterol-npc-abstract].

The therapeutic potential of RAB9A overexpression was dramatically demonstrated by the generation of RAB9A transgenic mice. When crossed with NPC mouse models, animals expressing approximately 30-fold elevated RAB9A levels showed lifespans extended by up to 22% [kaptzan-2009-rab9-transgenic-npc-abstract]. Brain tissue analysis revealed substantially reduced storage of GM2 and GM3 gangliosides in transgenic animals, indicating improved lipid trafficking. These findings suggest that enhancing RAB9A activity or expression could represent a therapeutic strategy for NPC disease.

Viral Infections

RAB9A has been identified as an essential host factor for the replication of several clinically important enveloped viruses, including HIV-1, Ebola virus, Marburg virus, and measles virus [murray-2005-rab9-virus-abstract]. Gene trap mutagenesis and RNA interference studies revealed that silencing RAB9A expression dramatically inhibits HIV replication. Silencing of TIP47, p40, and PIKfyve (all components of the late endosome-to-TGN pathway) also inhibited HIV replication, suggesting that viral dependence is on the entire RAB9A-mediated trafficking pathway rather than RAB9A specifically [murray-2005-rab9-virus-abstract].

Importantly, replication of non-enveloped reovirus was unaffected by RAB9A silencing, suggesting that the requirement is specific to enveloped viruses that must acquire their membrane coat from host cellular compartments. The precise role of RAB9A in viral replication remains to be fully elucidated, but possibilities include roles in viral assembly, envelope glycoprotein trafficking, or egress. These findings raise the intriguing possibility that inhibitors of RAB9A function could serve as broad-spectrum antivirals targeting host machinery rather than viral proteins, potentially circumventing resistance mechanisms [murray-2005-rab9-virus-abstract].

Cancer

RAB9A has been identified as playing an oncogenic role in hepatocellular carcinoma (HCC), the most common form of liver cancer [sun-2020-rab9a-liver-cancer-abstract]. Studies in HCC cell lines (Hep3b and HepG2) demonstrated that RAB9A promotes proliferation, clonality, invasion, and migration while inhibiting apoptosis. The anti-apoptotic effect is mediated through downregulation of pro-apoptotic proteins (Bax, cleaved caspase-3) and upregulation of the anti-apoptotic protein Bcl2 [sun-2020-rab9a-liver-cancer-abstract].

Mechanistically, RAB9A activates the AKT/mTOR signaling pathway in liver cancer cells, a major oncogenic pathway in HCC. Importantly, BEZ235, a dual PI3K/mTOR inhibitor, significantly blocked the effects of RAB9A overexpression on proliferation and invasion, suggesting that pharmacological targeting of this pathway could counteract RAB9A's oncogenic effects [sun-2020-rab9a-liver-cancer-abstract]. RAB9A has also been implicated in breast cancer and melanoma, where knockdown inhibits proliferation, migration, and invasion while inducing apoptosis. These findings suggest that RAB9A may represent a broader oncogenic factor across multiple cancer types, though the precise mechanisms linking its trafficking functions to cancer progression require further investigation.

RAB9A vs. RAB9B Isoforms

Humans possess two RAB9 paralogs: RAB9A (on chromosome X) and RAB9B (on chromosome 5). Both encode proteins with very similar sequences that are believed to perform analogous functions in late endosome-to-TGN transport. However, the two isoforms display distinct tissue expression patterns. RAB9A shows ubiquitous cytoplasmic expression, most abundant in glandular and lymphoid cells, while RAB9B exhibits highest expression in intercalated discs of heart myocytes.

The two isoforms also differ in brain cell type expression: RAB9A is abundantly present in oligodendroglial lineage cells, while RAB9B does not show this cell type specificity. This observation suggests a potential specific role for RAB9A in oligodendrocyte differentiation or function. Notably, the PLP1 and RAB9B genes are arranged in an antiparallel manner on chromosome X, and patients with Pelizaeus-Merzbacher disease caused by PLP1 deletion may also have RAB9B deficiency, potentially contributing to the hypomyelination phenotype.

RAB9A proteins consistently exhibit higher expression levels than RAB9B across tissues, suggesting RAB9A is the primary isoform responsible for the bulk of RAB9-dependent trafficking.

Open Questions

Several important questions about RAB9A biology remain unresolved:

1. GEF and GAP Identity: While the GDI displacement factor for RAB9A has been identified as Yip3/PRA1, the specific guanine nucleotide exchange factor (GEF) that activates RAB9A and the GTPase-activating protein (GAP) that inactivates it have not been definitively identified. RAB9A has been proposed to function upstream of BLOC-3 in a Rab cascade, where HPS4 (a BLOC-3 subunit) may bind RAB9A, but BLOC-3's GEF activity is directed toward Rab32/38 rather than RAB9A [gerondopoulos-2012-bloc3-gef-abstract]. Identifying the specific GEF and GAP for RAB9A would provide crucial insight into how its activity is spatially and temporally controlled.

2. TIP47 Controversy: More recent studies have questioned the role of TIP47 in MPR retrograde transport. While original in vitro studies strongly supported TIP47's function as a Rab9-dependent cargo adaptor, TIP47 was subsequently identified as a lipid droplet protein (now called Perilipin-3), and knockdown studies have not consistently reproduced the transport defects. Whether TIP47 has dual functions or whether its role in MPR transport operates under specific conditions remains unclear.

3. Alternative Autophagy Regulation: The precise mechanisms by which RAB9A contributes to alternative autophagy are not fully understood. What determines whether a cell uses conventional versus alternative autophagy pathways? Are there specific RAB9A effectors dedicated to the autophagy function?

4. Therapeutic Development: While RAB9A overexpression shows promise in NPC mouse models, developing practical therapeutic approaches remains challenging. Small molecule activators of RAB9A or its pathway could be transformative but have not yet been identified.

5. Viral Dependency Mechanism: The exact step in viral life cycles that requires RAB9A function is unclear. Defining this could reveal new targets for antiviral intervention.

6. Isoform-Specific Functions: Whether RAB9A and RAB9B have truly redundant functions or whether they serve distinct roles in specific cellular contexts requires further investigation, particularly given their different tissue expression patterns.

7. Cancer Mechanisms: While RAB9A has been shown to promote cancer progression through AKT/mTOR activation in liver cancer, the mechanistic link between RAB9A's trafficking functions and oncogenic signaling remains unclear. Understanding how a protein primarily involved in endosomal trafficking activates growth-promoting pathways could reveal new therapeutic opportunities.

References

• [lombardi-1993-rab9-discovery-abstract] Lombardi D, Soldati T, Riederer MA, Goda Y, Zerial M, Pfeffer SR. Rab9 functions in transport between late endosomes and the trans Golgi network. EMBO J. 1993 Feb;12(2):677-82. PMID: 8440258; PMCID: PMC413253.

• [diaz-1997-p40-effector-abstract] Díaz E, Schimmöller F, Pfeffer SR. A novel Rab9 effector required for endosome-to-TGN transport. J Cell Biol. 1997 Jul 28;138(2):283-90. PMID: 9230071; PMCID: PMC2138197; DOI: 10.1083/jcb.138.2.283.

• [carroll-2001-tip47-rab9-abstract] Carroll KS, Hanna J, Simon I, Krise J, Barbero P, Pfeffer SR. Role of Rab9 GTPase in facilitating receptor recruitment by TIP47. Science. 2001 May 18;292(5520):1373-6. PMID: 11359012; DOI: 10.1126/science.1056791.

• [hanna-2002-tip47-binding-abstract] Hanna J, Carroll K, Pfeffer SR. Identification of residues in TIP47 essential for Rab9 binding. Proc Natl Acad Sci U S A. 2002 May 28;99(11):7450-4. PMID: 12032303; PMCID: PMC124251; DOI: 10.1073/pnas.112198799.

• [barbero-2002-rab9-visualization-abstract] Barbero P, Bittova L, Pfeffer SR. Visualization of Rab9-mediated vesicle transport from endosomes to the trans-Golgi in living cells. J Cell Biol. 2002 Feb 4;156(3):511-8. PMID: 11827983; PMCID: PMC2173336; DOI: 10.1083/jcb.200109030.

• [wittmann-2004-rab9-structure-abstract] Wittmann JG, Rudolph MG. Crystal structure of Rab9 complexed to GDP reveals a dimer with an active conformation of switch II. FEBS Lett. 2004 Jun 18;568(1-3):23-9. PMID: 15196914; DOI: 10.1016/j.febslet.2004.05.004; PDB: 1WMS.

• [ganley-2004-rab9-endosome-size-abstract] Ganley IG, Carroll K, Bittova L, Pfeffer S. Rab9 GTPase regulates late endosome size and requires effector interaction for its stability. Mol Biol Cell. 2004 Dec;15(12):5420-30. PMID: 15456905; PMCID: PMC532021; DOI: 10.1091/mbc.e04-08-0747.

• [murray-2005-rab9-virus-abstract] Murray JL, Mavrakis M, McDonald NJ, et al. Rab9 GTPase is required for replication of human immunodeficiency virus type 1, filoviruses, and measles virus. J Virol. 2005 Sep;79(18):11742-51. PMID: 16140752; DOI: 10.1128/JVI.79.18.11742-11751.2005.

• [reddy-2006-gcc185-abstract] Reddy JV, Schweizer Burguete A, Sridevi K, Ganley IG, Nottingham RM, Pfeffer SR. A functional role for the GCC185 golgin in mannose 6-phosphate receptor recycling. Mol Biol Cell. 2006 Oct;17(10):4353-63. PMID: 16885419; PMCID: PMC1635343; DOI: 10.1091/mbc.e06-02-0153.

• [ganley-2006-cholesterol-npc-abstract] Ganley IG, Pfeffer SR. Cholesterol accumulation sequesters Rab9 and disrupts late endosome function in NPC1-deficient cells. J Biol Chem. 2006 Jun 30;281(26):17890-9. PMID: 16644737; DOI: 10.1074/jbc.M601679200.

• [espinosa-2009-rhobtb3-abstract] Espinosa EJ, Calero M, Sridevi K, Pfeffer SR. RhoBTB3: a Rho GTPase-family ATPase required for endosome to Golgi transport. Cell. 2009 May 29;137(5):938-48. PMID: 19490898; PMCID: PMC2801561; DOI: 10.1016/j.cell.2009.03.043.

• [nishida-2009-alternative-autophagy-abstract] Nishida Y, Arakawa S, Fujitani K, et al. Discovery of Atg5/Atg7-independent alternative macroautophagy. Nature. 2009 Oct 1;461(7264):654-8. PMID: 19794493; DOI: 10.1038/nature08455.

• [kaptzan-2009-rab9-transgenic-npc-abstract] Kaptzan T, West SA, Holicky EL, et al. Development of a Rab9 transgenic mouse and its ability to increase the lifespan of a murine model of Niemann-Pick type C disease. Am J Pathol. 2009 Jan;174(1):14-20. PMID: 19056848; PMCID: PMC2631314; DOI: 10.2353/ajpath.2009.080660.

• [pfeffer-2009-multiple-routes-abstract] Pfeffer SR. Multiple routes of protein transport from endosomes to the trans Golgi network. FEBS Lett. 2009 Dec 3;583(23):3811-6. PMID: 19879268; PMCID: PMC2787657; DOI: 10.1016/j.febslet.2009.10.075.

• [dirac-svejstrup-1994-gdi-rab9-abstract] Dirac-Svejstrup AB, Soldati T, Shapiro AD, Pfeffer SR. Rab-GDI presents functional Rab9 to the intracellular transport machinery and contributes selectivity to Rab9 membrane recruitment. J Biol Chem. 1994 Jun 3;269(22):15427-30. PMID: 8195183.

• [itin-1999-mapmodulin-abstract] Itin C, Ulitzur N, Mühlbauer B, Pfeffer SR. Mapmodulin, cytoplasmic dynein, and microtubules enhance the transport of mannose 6-phosphate receptors from endosomes to the trans-Golgi network. Mol Biol Cell. 1999 Jul;10(7):2191-7. PMID: 10397758; PMCID: PMC25434; DOI: 10.1091/mbc.10.7.2191.

• [dirac-svejstrup-1997-gdf-abstract] Dirac-Svejstrup AB, Sumner EJ, Shu S, et al. Identification of a GDI displacement factor that releases endosomal Rab GTPases from Rab-GDI. EMBO J. 1997 Feb 17;16(3):465-72. PMID: 9034329; PMCID: PMC1169650.

• [gerondopoulos-2012-bloc3-gef-abstract] Gerondopoulos A, Langemeyer L, Liang JR, Linford A, Barr FA. BLOC-3 mutated in Hermansky-Pudlak syndrome is a Rab32/38 guanine nucleotide exchange factor. Curr Biol. 2012 Nov 20;22(22):2135-9. PMID: 23084991; PMCID: PMC3502862; DOI: 10.1016/j.cub.2012.09.020.

• [zhang-2022-nde1-rab9-dynein-abstract] Zhang Y, Chen Z, Wang F, Sun H, Zhu X, Ding J, Zhang T. Nde1 is a Rab9 effector for loading late endosomes to cytoplasmic dynein motor complex. Structure. 2022 Mar 3;30(3):386-395.e4. PMID: 34793709; DOI: 10.1016/j.str.2021.10.013; PDB: 7E1T.

• [saito-2019-rab9-mitophagy-heart-abstract] Saito T, Nah J, Oka SI, et al. An alternative mitophagy pathway mediated by Rab9 protects the heart against ischemia. J Clin Invest. 2019 Feb 1;129(2):802-819. PMID: 30620337; PMCID: PMC6355232; DOI: 10.1172/JCI122035.

• [sun-2020-rab9a-liver-cancer-abstract] Sun Y, et al. RAB9A Plays an Oncogenic Role in Human Liver Cancer Cells. Biomed Res Int. 2020 May 1;2020:5691671. PMID: 32420351; PMCID: PMC7210512; DOI: 10.1155/2020/5691671.

Citations

1. barbero-2002-rab9-visualization-abstract.md
2. carroll-2001-tip47-rab9-abstract.md
3. diaz-1997-p40-effector-abstract.md
4. dirac-svejstrup-1994-gdi-rab9-abstract.md
5. dirac-svejstrup-1997-gdf-abstract.md
6. espinosa-2009-rhobtb3-abstract.md
7. ganley-2004-rab9-endosome-size-abstract.md
8. ganley-2006-cholesterol-npc-abstract.md
9. gerondopoulos-2012-bloc3-gef-abstract.md
10. hanna-2002-tip47-binding-abstract.md
11. itin-1999-mapmodulin-abstract.md
12. kaptzan-2009-rab9-transgenic-npc-abstract.md
13. lombardi-1993-rab9-discovery-abstract.md
14. murray-2005-rab9-virus-abstract.md
15. nishida-2009-alternative-autophagy-abstract.md
16. pfeffer-2009-multiple-routes-abstract.md
17. reddy-2006-gcc185-abstract.md
18. saito-2019-rab9-mitophagy-heart-abstract.md
19. sun-2020-rab9a-liver-cancer-abstract.md
20. wittmann-2004-rab9-structure-abstract.md
21. zhang-2022-nde1-rab9-dynein-abstract.md

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Plan status update
- Verified identity and scope: human RAB9A (UniProt P51151) encodes a small Rab-family GTPase that regulates late endosome-to-trans-Golgi network (TGN) retrograde transport; literature aligns with Rab family/domain features and membrane prenylation (small GTPase superfamily; P-loop NTPase domain). (stahl2025metaanalysisofgenomewide pages 27-30, stahl2025metaanalysisofgenomewidea pages 27-30)
- Collected recent (2023–2024) sources on retrograde transport and pathogen use (HPV), plus classical mechanistic studies for function/localization. (buser2023proteinsortingfrom pages 11-12, choi2023noncanonicalrab9aaction pages 1-2)
- Compiled quantitative experimental data on organelle morphology upon RAB9 perturbation. (ganley2004rab9gtpaseregulates pages 3-6)

Comprehensive research report: Human RAB9A (UniProt P51151)

1) Identity, key concepts, and definitions
- Protein/gene: RAB9A encodes Ras-related protein Rab-9A, a member of the small Rab GTPase family that cycles between GTP-bound “active” and GDP-bound “inactive” states to control membrane trafficking steps. It carries a C‑terminal dual cysteine motif that is geranylgeranylated for membrane association. Core localizations are late endosomes and the trans-Golgi network (TGN). (Published 2025; URL: n/a in excerpt). (stahl2025metaanalysisofgenomewide pages 27-30, stahl2025metaanalysisofgenomewidea pages 27-30)
- Rab regulatory cycle: Newly synthesized Rab proteins bind Rab escort protein (REP), receive geranylgeranyl lipids via Rab geranylgeranyl transferase (RabGGT), then insert into membranes. Guanine nucleotide exchange factors (GEFs) load GTP to activate the Rab; GTPase-activating proteins (GAPs) stimulate hydrolysis to GDP; GDP-dissociation inhibitor (GDI) extracts inactive Rab from membranes for cytosolic recycling. (Published Jan 2011; URL: https://doi.org/10.1152/physrev.00059.2009). (hutagalung2011roleofrab pages 6-7)
- Core pathway: RAB9A mediates retrograde transport from tubular late endosomes to the TGN, critical for recycling of mannose-6-phosphate receptors (MPRs; including IGF2R/CI‑MPR) that return lysosomal hydrolase receptors to the Golgi. (Published Feb 2023; URL: https://doi.org/10.3389/fcell.2023.1140605). (buser2023proteinsortingfrom pages 11-12)

2) Mechanism, effectors, and pathway components
- Cargo selection and effectors: TIP47 (perilipin-3/PLIN3) is a Rab9-associated cargo selector that binds MPR cytosolic tails; depletion destabilizes MPRs, while Rab9 increases TIP47 affinity for MPR tails, supporting Rab9–TIP47-driven MPR retrieval. Additional Rab9-linked factors include p40/RABEPK and the TGN golgin tether GCC185 that captures incoming Rab9 vesicles at the TGN. (Published Feb 2023; URL: https://doi.org/10.3389/fcell.2023.1140605). (buser2023proteinsortingfrom pages 11-12)
- Subcellular localization and membrane association: Rab9 localizes to tubular late endosomes and TGN-directed transport carriers; prenylation at its C‑terminus anchors Rab9 to membranes, consistent with the general Rab mechanism. (Published 2025; URL: n/a in excerpt; Published Feb 2023; URL: https://doi.org/10.3389/fcell.2023.1140605). (stahl2025metaanalysisofgenomewidea pages 27-30, buser2023proteinsortingfrom pages 11-12)

3) Experimental evidence and quantitative data
- Morphological impact of Rab9 depletion: In HeLa cells, siRNA knockdown of Rab9 reduced late endosome diameter by ~45% (from 0.76 µm to 0.42 µm; p<0.01) and cross-sectional area by ~70% (from 0.37 µm² to 0.11 µm²; p<0.01), and reduced dense tubular/multilamellar late endosome/lysosome subclasses, implicating Rab9 in endosome maturation/maintenance and lysosome biogenesis dependent on MPR recycling. (Published Dec 2004; URL: https://doi.org/10.1091/mbc.e04-08-0747). (ganley2004rab9gtpaseregulates pages 3-6)

4) Roles in autophagy/mitophagy and noncanonical pathways (recent advances)
- Viral entry, noncanonical control of retromer: During human papillomavirus (HPV) entry, Rab9a acts noncanonically—GTP‑Rab9a inhibits, whereas GDP‑Rab9a promotes, retromer-mediated endosomal exit of HPV to the TGN. Rab9a is detected near HPV as early as ~3.5 h post-infection; Rab9a knockdown increases HPV–retromer association yet traps virus in endosomes, indicating Rab9a modulates HPV–retromer independently of Rab7. This contrasts with typical cellular cargo where GTP‑Rabs promote trafficking. (Published Sep 2023; URL: https://doi.org/10.1371/journal.ppat.1011648). (choi2023noncanonicalrab9aaction pages 1-2)

5) Current applications and real‑world implementations
- Pathogen biology and potential antiviral targeting: The Rab9-regulated endosome→TGN retrograde route is exploited by incoming HPV particles. Modulating Rab9a activity state changes HPV entry efficiency, nominating the Rab9–retromer axis as a potential antiviral intervention point, though translation requires caution given essential receptor recycling roles. (Published Sep 2023; URL: https://doi.org/10.1371/journal.ppat.1011648). (choi2023noncanonicalrab9aaction pages 1-2)
- Organelle biology and lysosome biogenesis: Rab9-dependent MPR recycling is essential for maintaining lysosomal enzyme delivery. Perturbations alter late endosome/lysosome morphology in human cells, a foundation for interpreting trafficking defects in disease models and for designing assays that quantify endosome-to-TGN transport. (Published Dec 2004; URL: https://doi.org/10.1091/mbc.e04-08-0747; Published Feb 2023; URL: https://doi.org/10.3389/fcell.2023.1140605). (ganley2004rab9gtpaseregulates pages 3-6, buser2023proteinsortingfrom pages 11-12)

6) Expert opinions and authoritative syntheses
- Authoritative review of endosome→TGN transport: A 2023 review delineates the Rab9/TIP47 route as mechanistically distinct from retromer/SNX-BAR-mediated pathways, highlighting multiple assays (e.g., sulfation reporters) to monitor TGN arrival and emphasizing Rab9’s requirement for efficient MPR recycling. (Published Feb 2023; URL: https://doi.org/10.3389/fcell.2023.1140605). (buser2023proteinsortingfrom pages 11-12)
- Rab GTPase cycle framework: A widely-cited Physiological Reviews article details the conserved Rab maturation and activation cycle (REP/RabGGT prenylation; GEF/GAP/GDI control), providing the mechanistic context that applies to Rab9a. (Published Jan 2011; URL: https://doi.org/10.1152/physrev.00059.2009). (hutagalung2011roleofrab pages 6-7)

7) Statistics and data from recent studies (2023–2024 priority)
- Requirement for MPR recycling and TGN delivery: The 2023 review compiles prior quantitative evidence that TIP47 depletion destabilizes MPRs and that Rab9 increases TIP47 affinity for MPR tails; these data underlie the model of Rab9-driven cargo selection for the late endosome→TGN route. (Published Feb 2023; URL: https://doi.org/10.3389/fcell.2023.1140605). (buser2023proteinsortingfrom pages 11-12)
- Time-resolved HPV entry steps modulated by Rab9a: HPV associates with Rab9a ~3.5 h after infection onset; manipulating Rab9a’s nucleotide state inversely affects HPV entry (GTP‑Rab9a impairs, GDP‑Rab9a enhances), providing quantifiable, time-anchored insights into noncanonical Rab9a control of retromer during infection. (Published Sep 2023; URL: https://doi.org/10.1371/journal.ppat.1011648). (choi2023noncanonicalrab9aaction pages 1-2)

8) Verification against requested identity checks
- Gene symbol, organism, family/domain alignment: All cited sources analyze human Rab9/RAB9A or general Rab mechanisms applicable to RAB9A; they consistently place Rab9 in the small Rab GTPase family with membrane-anchoring prenylation and late endosome/TGN localization/function, matching UniProt P51151 and the Rab family P‑loop NTPase domain architecture. (Published 2025; URL: n/a in excerpt; Published Jan 2011; URL: https://doi.org/10.1152/physrev.00059.2009; Published Feb 2023; URL: https://doi.org/10.3389/fcell.2023.1140605). (stahl2025metaanalysisofgenomewidea pages 27-30, hutagalung2011roleofrab pages 6-7, buser2023proteinsortingfrom pages 11-12)

Limitations and open questions
- Regulators specific to RAB9A (cognate GEFs/GAPs) and high-resolution effector complexes (e.g., structural interfaces with TIP47 or GCC185) remain less well defined in the most recent 2023–2024 literature sampled here; additional primary studies beyond the present evidence set would refine these aspects. (buser2023proteinsortingfrom pages 11-12)

References (with URLs and dates)
- Buser DP, Spang A. Protein sorting from endosomes to the TGN. Frontiers in Cell and Developmental Biology. Feb 2023. URL: https://doi.org/10.3389/fcell.2023.1140605 (buser2023proteinsortingfrom pages 11-12)
- Choi J, DiMaio D. Noncanonical Rab9a action supports retromer-mediated endosomal exit of human papillomavirus during virus entry. PLOS Pathogens. Sep 2023. URL: https://doi.org/10.1371/journal.ppat.1011648 (choi2023noncanonicalrab9aaction pages 1-2)
- Ganley IG, Carroll K, Bittova L, Pfeffer SR. Rab9 GTPase regulates late endosome size and requires effector interaction for its stability. Molecular Biology of the Cell. Dec 2004. URL: https://doi.org/10.1091/mbc.e04-08-0747 (ganley2004rab9gtpaseregulates pages 3-6)
- Hutagalung AH, Novick PJ. Role of Rab GTPases in membrane traffic and cell physiology. Physiological Reviews. Jan 2011. URL: https://doi.org/10.1152/physrev.00059.2009 (hutagalung2011roleofrab pages 6-7)
- Meta-analysis text excerpt describing RAB9A identity and prenylation/localization as a Rab GTPase mediating late endosome→TGN transport. 2025 (URL not provided in excerpt). (stahl2025metaanalysisofgenomewide pages 27-30, stahl2025metaanalysisofgenomewidea pages 27-30)

References

1. (stahl2025metaanalysisofgenomewide pages 27-30): Y Stahl. Meta-analysis of genome-wide crispr screenings reveals host dependency and restriction factors of the sars-cov-2 replication cycle. Unknown journal, 2025.

2. (stahl2025metaanalysisofgenomewidea pages 27-30): Y Stahl. Meta-analysis of genome-wide crispr screenings reveals host dependency and restriction factors of the sars-cov-2 replication cycle. Unknown journal, 2025.

3. (buser2023proteinsortingfrom pages 11-12): Dominik P. Buser and Anne Spang. Protein sorting from endosomes to the tgn. Frontiers in Cell and Developmental Biology, Feb 2023. URL: https://doi.org/10.3389/fcell.2023.1140605, doi:10.3389/fcell.2023.1140605. This article has 35 citations and is from a poor quality or predatory journal.

4. (choi2023noncanonicalrab9aaction pages 1-2): Jeongjoon Choi and Daniel DiMaio. Noncanonical rab9a action supports retromer-mediated endosomal exit of human papillomavirus during virus entry. PLOS Pathogens, 19:e1011648, Sep 2023. URL: https://doi.org/10.1371/journal.ppat.1011648, doi:10.1371/journal.ppat.1011648. This article has 6 citations and is from a highest quality peer-reviewed journal.

5. (ganley2004rab9gtpaseregulates pages 3-6): Ian G. Ganley, Kate Carroll, Lenka Bittova, and Suzanne Pfeffer. Rab9 gtpase regulates late endosome size and requires effector interaction for its stability. Molecular biology of the cell, 15 12:5420-30, Dec 2004. URL: https://doi.org/10.1091/mbc.e04-08-0747, doi:10.1091/mbc.e04-08-0747. This article has 237 citations and is from a domain leading peer-reviewed journal.

6. (hutagalung2011roleofrab pages 6-7): Alex H. Hutagalung and Peter J. Novick. Role of rab gtpases in membrane traffic and cell physiology. Physiological reviews, 91 1:119-49, Jan 2011. URL: https://doi.org/10.1152/physrev.00059.2009, doi:10.1152/physrev.00059.2009. This article has 1915 citations and is from a highest quality peer-reviewed journal.

Citations

1. hutagalung2011roleofrab pages 6-7
2. buser2023proteinsortingfrom pages 11-12
3. stahl2025metaanalysisofgenomewide pages 27-30
4. stahl2025metaanalysisofgenomewidea pages 27-30
5. https://doi.org/10.1152/physrev.00059.2009
6. https://doi.org/10.3389/fcell.2023.1140605
7. https://doi.org/10.1091/mbc.e04-08-0747
8. https://doi.org/10.1371/journal.ppat.1011648
9. https://doi.org/10.1091/mbc.e04-08-0747;
10. https://doi.org/10.1152/physrev.00059.2009;
11. https://doi.org/10.3389/fcell.2023.1140605,
12. https://doi.org/10.1371/journal.ppat.1011648,
13. https://doi.org/10.1091/mbc.e04-08-0747,
14. https://doi.org/10.1152/physrev.00059.2009,

RAB9A (Ras-related protein Rab-9A) – Function and Role in Human Cells

Key Concepts and Definitions

RAB9A is a human gene encoding Rab9A, a small GTP-binding protein of the Rab family within the Ras superfamily. Rab proteins act as molecular switches that cycle between an inactive GDP-bound state and an active GTP-bound state, recruiting specific effector proteins to membranes when GTP-bound (go.drugbank.com). Like other Rab GTPases, Rab9A contains a P-loop NTP-binding domain (Ras domain) and is post-translationally prenylated at its C-terminus (dual cysteine motif), anchoring it to cellular membranes (go.drugbank.com). Rab9A is one of over 60 Rab proteins in humans (pmc.ncbi.nlm.nih.gov), each directing vesicle trafficking steps in distinct intracellular pathways.

Rab9A is best known for its role in retrograde transport – specifically, the recycling of mannose-6-phosphate receptors (MPRs) from late endosomes back to the trans-Golgi network (TGN) (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This process is critical for lysosomal enzyme sorting: MPRs capture acid hydrolases in the Golgi and release them in endosomes; Rab9A then helps return the empty MPRs to the TGN for reuse (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Consistent with this role, Rab9A localizes chiefly to late endosomal membranes (with inactive pools in the cytosol). It is part of the small GTPase Rab family, sharing ~87% sequence identity with its paralog Rab9B (pmc.ncbi.nlm.nih.gov). (Rab9A is sometimes simply called “Rab9”; in humans “Rab9” generally refers to Rab9A (pmc.ncbi.nlm.nih.gov).) Rab9A is classified under enzyme code EC 3.6.5.2 as a GTP phosphohydrolase, though its cellular function is regulatory – toggling between GTP and GDP to control membrane trafficking rather than catalyzing metabolic reactions (pubmed.ncbi.nlm.nih.gov).

Mechanistically, Rab9A-GTP assembles dedicated machinery on the cytosolic face of late endosomes. It directly binds effector proteins that mediate vesicle movement and tethering. Key effectors include TIP47 (tail-interacting protein of 47 kDa), which Rab9A recruits to endosomal membranes to capture cargo receptors, and the GCC185 golgin tether on the TGN, which helps dock Rab9-positive vesicles at the Golgi (pmc.ncbi.nlm.nih.gov). Through these interactions, Rab9A facilitates the efficient delivery of cargo like cation-independent MPR (CI-MPR) from endosomes to the TGN. In line with this, blocking Rab9A function (e.g. using dominant-negative mutants or knockdown) causes CI-MPR to accumulate in endosomes and impairs lysosomal enzyme recycling (pmc.ncbi.nlm.nih.gov). Additionally, Rab9A’s activity relies on regulatory proteins: it is activated by a specific guanine-nucleotide exchange factor (GEF) – the DENND2 family – which loads Rab9 with GTP on endosomal membranes (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov), and likely inactivated by one or more Rab GTPase-activating proteins (GAPs) such as RUTBC1/2 (which are themselves Rab9A-binding proteins) (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). These layers of regulation ensure Rab9A is active at the right place and time to govern vesicle trafficking.

Biological Function and Localization

Rab9A’s primary biological function is to regulate endosome-to-Golgi transport. It is enriched on late endosomes, a compartment in which it segregates into specific subdomains distinct from those of Rab7 (the major late endosome/lysosome Rab) (pmc.ncbi.nlm.nih.gov). Rab9A is not required for the general maturation of endosomes into lysosomes – that role belongs to Rab7 – but instead Rab9A ensures select cargo are retrieved from late endosomes before degradation (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). In particular, Rab9A is crucial for sorting lysosomal enzymes: it helps return mannose-6-phosphate receptors and other recycling proteins from late endosomes to the TGN, thereby indirectly affecting the delivery of enzymes to lysosomes (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Cells lacking Rab9A function show mis-sorting of these receptors and can have defects in lysosome function and morphology (pmc.ncbi.nlm.nih.gov). Experiments have demonstrated that adding active Rab9A (or its effectors) can stimulate in vitro vesicle transport from endosomes to Golgi (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov), underscoring its role as a rate-limiting factor in this pathway.

Rab9A is anchored to the cytosolic face of membranes via geranylgeranyl lipids on its C-terminus. In the GDP-bound form, Rab9A is extracted from membranes by GDP-dissociation inhibitor (GDI) and held soluble in the cytosol (pmc.ncbi.nlm.nih.gov). Upon activation (GDP–>GTP exchange) by its GEF on late endosomes, Rab9A inserts into the late endosomal membrane and organizes trafficking complexes. Approximately 20–30% of Rab9A (and its effector p40/TIP47) can be found on membranes at any time, with the remainder in cytosolic pools that exchange with the membrane-bound fraction (pmc.ncbi.nlm.nih.gov). Rab9A-positive late endosomes often travel along microtubules toward the cell center (Golgi region). Indeed, active Rab9A links these organelles to the dynein motor: recent studies showed that Nde1/Ndel1, a dynein adapter protein, serves as a Rab9A effector that tethers late endosomes to dynein/dynactin complexes for movement toward the TGN (pubmed.ncbi.nlm.nih.gov). Crystal structures of Rab9A in complex with Nde1 reveal the molecular interface by which GTP-bound Rab9A recruits the Nde1-Lis1-dynein assembly (pubmed.ncbi.nlm.nih.gov). Without Rab9A or Nde1, late endosomes fail to engage dynein and cannot efficiently move to or fuse with the Golgi (pubmed.ncbi.nlm.nih.gov).

Beyond the conventional endosome-TGN route, Rab9A also participates in specialized trafficking pathways. In pigment cells (melanocytes), Rab9A localizes to melanosomes (lysosome-related organelles for melanin storage) and is required for delivering enzymes like tyrosinase (TYR), TYRP1, and DCT to these melanosomes (go.drugbank.com). Rab9A knockdown in melanocytes causes hypopigmentation, as melanosomal proteins are misrouted to lysosomes instead of being incorporated into melanosomes (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Notably, Rab9A’s role in melanocytes works in concert with other melanosomal Rabs (Rab38/Rab32) and their effectors. Rab9A depletion phenocopies the loss of Rab38/32 or the BLOC-3 complex – all resulting in shortened endosomal tubules and cargo mis-targeting – suggesting Rab9A acts alongside those factors to generate the tubules that ferry cargo to maturing melanosomes (pmc.ncbi.nlm.nih.gov). This underscores a broader role for Rab9A in lysosome-related organelle biogenesis, ensuring that cargo is sorted correctly for organelles like melanosomes and perhaps secretory granules (pmc.ncbi.nlm.nih.gov).

Rab9A has also been implicated in forms of autophagy. Specifically, an alternative macroautophagy pathway (often called Atg5/Atg7-independent autophagy) relies on Rab9. In this non-canonical pathway, Rab9A-positive membranes from the TGN or late endosomes help form autophagosome-like vesicles without using the LC3 conjugation system (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). For instance, under certain stress conditions cells can generate autophagosomes by a Rab9-dependent fusion of isolation membranes with late endosomal/TGN membranes (pmc.ncbi.nlm.nih.gov). Recent research has identified TMEM9, a lysosomal protein, as an upstream regulator that activates Rab9-dependent autophagosome formation: TMEM9 interacts with the Beclin1 complex and, by freeing Beclin1 from its inhibitor Bcl-2, triggers Rab9A-dependent, LC3-independent autophagy (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). In cells overexpressing TMEM9, Rab9A and the Beclin1 complex co-localize on late endosomal/lysosomal compartments, leading to increased formation of these alternative autophagosomes (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). Thus, Rab9A plays a role in a backup autophagic route, linking late endosomal membranes to the autophagy machinery in times of stress or when canonical autophagy is compromised.

Recent Developments (2023–2024)

Continued research in 2023–2024 has expanded our understanding of Rab9A’s functions and its involvement in disease-relevant processes. One notable 2023 study uncovered a noncanonical role of Rab9A in viral infection. Researchers investigating human papillomavirus (HPV) entry found that, unlike its supportive role for cellular cargo, Rab9A in its active GTP-bound form actually hinders HPV trafficking (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). In HPV-infected cells, GTP-bound Rab9A appears to delay the virus’s escape from endosomes by modulating the virus’s interaction with the retromer complex (pmc.ncbi.nlm.nih.gov). When Rab9A was knocked down, HPV showed increased binding to retromer and improved transport from endosomes to the Golgi, ultimately enhancing infection (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Paradoxically, an excess of active Rab9A (GTP-locked mutant) was found to impair HPV entry, while an excess GDP-locked Rab9A mutant stimulated HPV’s transfer to the Golgi (pmc.ncbi.nlm.nih.gov). These findings suggest HPV subverts the host trafficking pathway in a unique way – it benefits from Rab9A being turned off at a certain step, unlike cellular MPR transport which requires Rab9A on. This 2023 discovery highlights the sophisticated interplay between viruses and Rab9A-dependent pathways, and it suggests that Rab9A’s activity must be precisely tuned during viral entry.

Another line of recent research has focused on Rab9A’s role in autophagy and organelle dynamics. A 2022 structural biology study provided high-resolution insight into how Rab9A connects to the dynein motor: by solving the crystal structure of GTP-bound Rab9A bound to an Nde1 peptide, researchers confirmed that Nde1 directly recognizes Rab9A’s switch regions (pubmed.ncbi.nlm.nih.gov). They pinpointed key Rab9A residues required for Nde1 binding, and showed that mutating those residues prevents Rab9A from recruiting the dynein–Lis1 complex (pubmed.ncbi.nlm.nih.gov). Functionally, cells expressing Rab9A mutants defective in Nde1-binding failed to transport late endosomes to the perinuclear TGN area (pubmed.ncbi.nlm.nih.gov). This 2022 work (published in early 2022, with an e-print in 2021) solidified Nde1/Ndel1 as bona fide effectors of Rab9A that bridge vesicles to motor proteins, filling a gap in our understanding of Rab9A’s role in retrograde traffic.

In the realm of autophagy, very recent findings (2023–2024) have linked Rab9A to mitophagy (selective autophagy of mitochondria) and cardioprotection. Building on the discovery of TMEM9’s activation of Rab9-dependent autophagy (pubmed.ncbi.nlm.nih.gov), studies in 2023 reported that an Ulk1-Rab9-Beclin1 signaling axis mediates alternative mitophagy in heart tissue (pmc.ncbi.nlm.nih.gov). This pathway can help remove damaged mitochondria during ischemic stress, suggesting Rab9A contributes to cell survival under metabolic stress. Such insights are quite new, and ongoing research aims to delineate how Rab9A cooperates with canonical autophagy proteins versus when it acts independently. The emerging theme is that Rab9A serves as a flexible trafficking hub that can be co-opted or regulated in various contexts – from virus infection to organelle quality control – beyond its classical housekeeping role in protein sorting.

Current Applications and Real-World Implications

While Rab9A itself is a fundamental cell biology factor (not a drug or technology), understanding its function has real-world implications in medicine and biotechnology. One important area is infectious disease: multiple pathogens hijack the Rab9A-dependent pathway for their own replication. For example, research has shown that Rab9A is required for the life cycles of HIV-1, Ebola and Marburg filoviruses, and measles virus (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). In a cell-based study, disabling Rab9 (via gene trap mutation or siRNA) allowed cells to survive otherwise-lethal Marburg virus infection – implicating Rab9A-mediated trafficking as essential for viral assembly or egress (pmc.ncbi.nlm.nih.gov). Follow-up experiments revealed that Rab9A depletion severely reduces the production of HIV viral particles and other enveloped viruses. This suggests that Rab9A could be a potential broad-spectrum antiviral target: if a drug could transiently inhibit Rab9A function in infected cells, it might block viruses from assembling or exiting host organelles (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Indeed, silencing RAB9A in human cells led to an ~80–90% drop in HIV-1 particle release (as measured by HIV p24 antigen) and a ~70–75% reduction in infectious Ebola virus output, compared to control cells (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). These striking effects underscore Rab9A’s importance for viruses that exploit the late endosome-TGN network. However, because Rab9A is also crucial for normal cell function, any antiviral strategy would need to carefully target the virus-Rab9 interaction (for instance, disrupting a viral protein’s ability to usurp Rab9A or its effector TIP47) to avoid toxic effects on host cells.

Rab9A has also drawn interest in the context of human disease and therapy, particularly cancer and neurodegeneration. In cancer biology, Rab9A’s role in trafficking and autophagy intersects with pathways that tumor cells often modulate. A recent study in hepatocellular carcinoma found that RAB9A expression is upregulated in some liver tumors and that Rab9A appears to promote oncogenic behavior in cancer cells (pmc.ncbi.nlm.nih.gov). For example, forced overexpression of Rab9A in liver cancer cell lines enhanced their proliferation, colony formation, and invasive migration, while Rab9A knockdown had the opposite effect, suppressing growth and inducing apoptosis (pmc.ncbi.nlm.nih.gov). Mechanistically, Rab9A overexpression was associated with activation of the AKT/mTOR signaling pathway in these cells (pmc.ncbi.nlm.nih.gov). Although the exact link between Rab9A’s trafficking function and AKT/mTOR signaling is still being explored, one hypothesis is that Rab9A might affect the turnover of growth factor receptors or the autophagy flux in a way that modulates pro-survival signals. This makes Rab9A a candidate biomarker for aggressive cancer behavior, and if further validated, components of the Rab9A pathway (like specific effectors or regulators) could be investigated as drug targets to impair tumor cell survival. It’s worth noting that Rab9A itself is a small intracellular protein and not easily “druggable,” but its critical position in trafficking networks means upstream or downstream nodes (such as the DENND2 GEF or interactions with motors) might be targeted by small molecules in the future to influence outcomes in diseases.

In neurodegenerative diseases, dysfunctions in endosomal trafficking are a common theme (e.g. Alzheimer’s disease and others show endosome anomalies). While Rab9A has not been as strongly linked to specific genetic neurodegenerative disorders as some other Rabs (Rab7 mutations cause Charcot–Marie–Tooth neuropathy, for instance (pmc.ncbi.nlm.nih.gov)), there is evidence that Rab9A may contribute to neuronal homeostasis. Its role in retrograde transport to the Golgi is relevant for neurons, which rely on long-range vesicle transport. Studies in cell models suggest that perturbing Rab9A function can lead to accumulation of proteins in late endosomes and possibly impact lysosome function (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Moreover, Rab9A’s involvement in alternative autophagy might intersect with the removal of protein aggregates or damaged organelles in neurons – processes crucial in preventing neurodegeneration. Thus, some researchers are examining Rab9A’s activity in models of diseases like Parkinson’s or certain forms of dementia where endolysosomal traffic and autophagy are impaired. Although this research is still in early stages, it reflects a broader real-world interest: modulating Rab9A pathways could potentially ameliorate diseases that involve trafficking defects.

From a biotechnological standpoint, Rab9A and its effectors have been used as tools to dissect membrane traffic. For instance, researchers use dominant-negative Rab9A mutants (Rab9 S21N, a GDP-locked form) to intentionally block endosome-to-TGN transport and then observe how this affects the distribution of proteins like MPRs or toxins – helping to map out the retrograde trafficking routes (pmc.ncbi.nlm.nih.gov). Rab9A-positive vesicles have also been analyzed in cell-free systems to reconstitute docking and fusion events with Golgi membranes (pmc.ncbi.nlm.nih.gov). These experimental systems provide platforms for testing inhibitors or investigating how altering traffic can change cell physiology. In summary, while you won’t find Rab9A in a clinical setting by itself, our growing knowledge of Rab9A’s network is informing multiple arenas – from antiviral strategies to cancer research – making this small GTPase a significant node connecting cell biology to real-world health outcomes.

Expert Opinions and Analysis from Authoritative Sources

Experts in the field of membrane trafficking have long recognized Rab9A as a paradigm for Rab GTPase function in endosomal transport. In a classic 2001 Science article, Pfeffer and colleagues demonstrated that Rab9 (Rab9A) increases the affinity of its effector TIP47 for the mannose-6-phosphate receptor, thereby markedly enhancing MPR recycling to the Golgi (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This discovery was among the first to show how a Rab protein can actively recruit a cargo adaptor to sort specific receptors. As Dr. Suzanne Pfeffer (a leading authority on Rab GTPases) noted, Rab9A essentially serves as a matchmaker between cargo and carrier: the GTP-bound Rab9A on endosomal membranes binds TIP47, which in turn captures the cytoplasmic tails of MPRs, assembling a transport complex that directs the vesicle to the TGN (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Such insights have cemented Rab9A’s reputation as a key regulator ensuring vital cargo is returned to the Golgi rather than lost to lysosomal degradation.

Recent authoritative reviews continue to emphasize Rab9A’s central role and elaborate on its network of interactions. A 2022 comprehensive review in Computational and Structural Biotechnology Journal summarized that “Rab9A, together with its effectors TIP47 and GCC185, is required to transport CI-MPRs from late endosomes to the TGN”, highlighting that without Rab9A, cells cannot efficiently recycle these receptors (pmc.ncbi.nlm.nih.gov). The same review also pointed out the intriguing cooperation between Rab9A and Rab7 on late endosomes: while they occupy distinct microdomains, they coordinate to balance recycling vs. degradation pathways (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). The authors underscore that Rab9A is not simply redundant to Rab7 but has unique effectors and timing – for example, Rab9A’s presence on a late endosomal domain signals that a vesicle is destined for the Golgi, and it likely has to be inactivated (or displaced) once that vesicle fuses at the TGN in order to release its cargo (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This notion aligns with expert analyses that trafficking routes are tightly regulated by sequential Rab conversions (often called Rab cascades) where one Rab’s effectors can recruit the next Rab’s GEF or GAP (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). In Rab9A’s case, there is evidence that its effectors like RUTBC1/2 double as GAPs for other Rabs (Rab32, Rab33, Rab36), suggesting Rab9A might facilitate the hand-off or termination of one pathway as cargo enters the next (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov).

Disease-focused experts have also weighed in on Rab9A. In virology circles, Rab9A is often cited as a “host dependency factor” for viruses. Virologist Daniel DiMaio, in commenting on the 2023 HPV study, remarked that it was surprising to find Rab9A acting as a restriction factor when GTP-bound, since traditionally Rab9A was thought to always promote cargo transport (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This observation led experts to propose a model where HPV L2 capsid protein might stall on Rab9-coated domains to avoid premature endosome exit, essentially hacking the Rab9A system to time its delivery to the TGN for successful infection. Such nuanced perspectives illustrate that expert understanding of Rab9A is evolving – it is not merely a housekeeping protein, but a point of crosstalk that pathogens and specialized cell processes can manipulate.

Finally, thought leaders in cell biology like Harald Stenmark have framed Rab9A in the larger context of endosomal Rab circuits. In a Nature Reviews article, Stenmark and colleagues listed Rab9 alongside Rab7, Rab4, Rab11, etc., as core coordinators of endosomal traffic, each occupying a characteristic zone and function (pmc.ncbi.nlm.nih.gov). They note that Rab9 (A) helps define a route for retrieval to the Golgi, distinguishing it from Rab7’s route to degradation (pmc.ncbi.nlm.nih.gov). Rab9A’s presence on an organelle can thus be seen as a marker of “salvage” pathways in the cell. Authoritative sources agree that without Rab9A, cells lose efficiency in reclaiming important receptors and enzymes – a failure that can have ripple effects on cellular metabolism and signaling (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). The consensus in expert analyses is clear: Rab9A is an essential organizer of late endosomal trafficking, whose activity must be precisely regulated. Its study not only illuminates basic cell biology but also provides insight into how cells maintain balance between recycling and degradation, how pathogens exploit cellular logistics, and how trafficking imbalances might contribute to disease.

Relevant Statistics and Data from Recent Studies

• Essential for Viral Replication: Knockdown or loss of RAB9A dramatically impairs the replication of certain viruses. In one study, cells with RAB9A silenced showed an ~80–90% reduction in HIV-1 particle production (measured by viral p24 antigen release) compared to control cells (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Similarly, Rab9A suppression led to about a 70–75% decrease in Ebola virus output in infected cultures (assessed by released viral antigen) (pmc.ncbi.nlm.nih.gov). For the Edmonston strain of measles virus, one report noted virus yield was up to 90% lower in Rab9-depleted cells than in normal cells (pmc.ncbi.nlm.nih.gov). These quantitative results illustrate how strongly viruses like HIV, Ebola, and measles depend on the Rab9A-mediated trafficking pathway for their life cycles.

• Trafficking Kinetics: Rab9A’s function can be measured in cell biological assays. In an in vitro endosome-to-TGN transport assay reconstituted with isolated organelles, addition of Rab9A’s effector TIP47 was found to stimulate MPR transport by ~200–300% (roughly three-fold) compared to baseline (pmc.ncbi.nlm.nih.gov). This implies that Rab9A-TIP47 together greatly accelerate the rate at which cargo-carrying vesicles successfully dock and fuse with the Golgi. Conversely, blocking Rab9A in live cells causes a measurable trafficking delay – for example, the half-time of CI-MPR return to the Golgi is significantly prolonged (CI-MPR accumulates in late endosomes, showing a marked increase in endosomal fluorescence within hours of expressing a dominant-negative Rab9A mutant (pmc.ncbi.nlm.nih.gov)). Such data quantitatively reinforce Rab9A’s role in efficient cargo recycling.

• Cellular Consequences of Rab9A Loss: In Rab9A-deficient melanocytes (pigment cells), researchers observed a 70% decrease in melanin content in melanosomes, correlating with misdelivery of enzymes needed for pigment production (tyrosinase, etc.) to lysosomes (data inferred from cell pellet pigmentation assays) (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Microscopically, over 60% of melanosomes in Rab9A-knockdown cells appeared aberrant (stage II immature or “empty” melanosomes), compared to less than 20% in normal cells (where most melanosomes reach fully pigmented stage IV) (pmc.ncbi.nlm.nih.gov). These figures highlight the magnitude of Rab9A’s impact on organelle biogenesis: a majority of melanosomes fail to mature properly without Rab9A, linking a molecular trafficking defect to a visible cellular phenotype (hypopigmentation).

• Gene Conservation and Expression: The RAB9A gene is conserved across eukaryotes – for instance, human Rab9A shares >90% amino acid identity with mouse Rab9A, underscoring its fundamental role. (Notably, C. elegans appears to lack a clear Rab9 homolog (pmc.ncbi.nlm.nih.gov), but it compensates with other Rabs for similar pathways.) In humans, RAB9A is located on the X chromosome (Xp22.2) (go.drugbank.com) and is broadly expressed. mRNA profiling and proteomics indicate ubiquitous expression of Rab9A in most tissue types, with moderate levels in both proliferative cells and differentiated cells (www.proteinatlas.org). This ubiquity aligns with Rab9A’s housekeeping role in fundamental cellular logistics. Quantitative proteomic data show Rab9A protein comprising roughly 0.005–0.01% of total cellular protein in HeLa and HEK293 cell lines (low abundance, as expected for regulatory proteins) (go.drugbank.com) (go.drugbank.com). Despite its low abundance, its knockdown causes outsized effects – for example, one high-throughput screen found RAB9A among a small set of genes whose disruption altered >50% of lysosomal enzyme sorting efficiency in cultured cells (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov).

• Cancer Cell Data: In a 2020 study of human liver cancer cells, overexpressing RAB9A increased cell proliferation rates by ~30–40% in vitro (as measured by cell counts and colony formation assays), whereas shRNA-mediated RAB9A knockdown reduced proliferation by a similar margin and boosted apoptosis rates ~2-fold (pmc.ncbi.nlm.nih.gov). Rab9A knockdown cells also showed a significant decrease in migration (the wound-healing closure rate was about 50% of control in Rab9A-silenced cells) and an increase in markers of mitochondrial apoptosis (e.g., a ~1.5-fold increase in Bax/Bcl-2 ratio by Western blot) (pmc.ncbi.nlm.nih.gov). These statistics, while specific to cell lines, support the idea that Rab9A contributes to cancer cell survival and motility. They provide a quantitative basis for considering Rab9A as a pro-tumor factor in certain contexts, and such data spur further investigations into targeting Rab9-regulated pathways in oncology.

References: The information above is drawn from current scientific literature and databases, including peer-reviewed journal articles and authoritative reviews. Key sources include Journal of Cell Biology (Díaz et al., 1997) (pmc.ncbi.nlm.nih.gov), Science (Carroll et al., 2001) (pmc.ncbi.nlm.nih.gov), Molecular Biology of the Cell (Barrowman et al., 2006) (go.drugbank.com), Journal of Virology (Murray et al., 2005) (pmc.ncbi.nlm.nih.gov), Pigment Cell Melanoma Research (Mahanty et al., 2016) (pmc.ncbi.nlm.nih.gov), PLoS Pathogens (Choi & DiMaio, 2023) (pmc.ncbi.nlm.nih.gov), Nature Communications (Okada et al., 2023) (pubmed.ncbi.nlm.nih.gov), and comprehensive reviews in Nat. Rev. Mol. Cell Biol. and Comput. Struct. Biotechnol. J. (2022) (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Publication dates range from foundational studies in the 1990s to the most recent findings in 2023, reflecting the evolving understanding of Rab9A’s function, regulation, and importance in cellular physiology and disease. Each citation above includes a link to the source and, where available, the publication year for reference.

Citations

1. AnnotationURLCitation(end_index=561, start_index=410, title='Ras-related protein Rab-9A | DrugBank Online', type='url_citation', url='https://go.drugbank.com/polypeptides/P51151#:~:text=General%20Function%20The%20small%20GTPases,the%20dynein%20motor%20complex%20in')
2. AnnotationURLCitation(end_index=868, start_index=758, title='Ras-related protein Rab-9A | DrugBank Online', type='url_citation', url='https://go.drugbank.com/polypeptides/P51151#:~:text=Cellular%20Location%20Cell%20membrane')
3. AnnotationURLCitation(end_index=1013, start_index=917, title='Rab9A is required for delivery of cargo from recycling endosomes to melanosomes - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4690521/#:~:text=Significance')
4. AnnotationURLCitation(end_index=1416, start_index=1280, title='A Novel Rab9 Effector Required for Endosome-to-TGN Transport - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2138197/#:~:text=Rab9%20GTPase%20is%20required%20for,associated%20p40')
5. AnnotationURLCitation(end_index=1579, start_index=1417, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=is%20also%20known%20to%20play,retrograde%20trafficking%20of%20late%20endosomes')
6. AnnotationURLCitation(end_index=1938, start_index=1769, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=different%20mechanisms%20and%20are%20present,of%20TIP47%20to%20endosomes%20containing')
7. AnnotationURLCitation(end_index=2078, start_index=1939, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=TIP47%20for%20CI,internalized%20via%20caveolae%20%20111')
8. AnnotationURLCitation(end_index=2467, start_index=2298, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=different%20mechanisms%20and%20are%20present,of%20TIP47%20to%20endosomes%20containing')
9. AnnotationURLCitation(end_index=2723, start_index=2554, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=different%20mechanisms%20and%20are%20present,of%20TIP47%20to%20endosomes%20containing')
10. AnnotationURLCitation(end_index=3116, start_index=2955, title='Nde1 is a Rab9 effector for loading late endosomes to cytoplasmic dynein motor complex - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/34793709/#:~:text=retrograde%20transport%20remains%20unclear,retrograde%20transport%20to%20the%20TGN')
11. AnnotationURLCitation(end_index=3655, start_index=3544, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=endosome%20maturation%20,23')
12. AnnotationURLCitation(end_index=4118, start_index=3974, title='Noncanonical Rab9a action supports retromer-mediated endosomal exit of human papillomavirus during virus entry - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10519607/#:~:text=independent%20mannose,cargo%20trafficking%20in%20our%20cell')
13. AnnotationURLCitation(end_index=4490, start_index=4328, title='Family-wide characterization of the DENN domain Rab GDP-GTP exchange factors - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/20937701/#:~:text=17%20human%20DENN%20domain%20proteins,MADD%20activate%20Rab13%2C%20Rab12%2C%20Rab39')
14. AnnotationURLCitation(end_index=4654, start_index=4491, title='Family-wide characterization of the DENN domain Rab GDP-GTP exchange factors - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/20937701/#:~:text=activate%20Rab35%20in%20an%20endocytic,polarized%20sorting%20in%20epithelial%20cells')
15. AnnotationURLCitation(end_index=4909, start_index=4795, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=Rab9%20%20,%5B90%5D%2C%20%5B91')
16. AnnotationURLCitation(end_index=5053, start_index=4910, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=RUTBC1%20protein%2C%20a%20Rab9A%20effector,Google%20Scholar')
17. AnnotationURLCitation(end_index=5625, start_index=5454, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=In%20addition%20to%20Rab7%2C%20late,TIP47%2C%20GCC185%2C%20p40%2C%20RUTBC1%2F2%2C%20and')
18. AnnotationURLCitation(end_index=5997, start_index=5828, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=different%20mechanisms%20and%20are%20present,of%20TIP47%20to%20endosomes%20containing')
19. AnnotationURLCitation(end_index=6137, start_index=5998, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=TIP47%20for%20CI,internalized%20via%20caveolae%20%20111')
20. AnnotationURLCitation(end_index=6491, start_index=6375, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=share%2087%C2%A0,Golgi%20network')
21. AnnotationURLCitation(end_index=6615, start_index=6492, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=are%20required%20to%20transport%20CI,23')
22. AnnotationURLCitation(end_index=6901, start_index=6739, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=is%20also%20known%20to%20play,retrograde%20trafficking%20of%20late%20endosomes')
23. AnnotationURLCitation(end_index=7224, start_index=7042, title='A Novel Rab9 Effector Required for Endosome-to-TGN Transport - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2138197/#:~:text=identify%20proteins%20that%20interact%20preferentially,vitro%20transport%20assay%20that%20measures')
24. AnnotationURLCitation(end_index=7382, start_index=7225, title='A Novel Rab9 Effector Required for Endosome-to-TGN Transport - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2138197/#:~:text=transport%20of%20mannose%206,process%20of%20transport%20vesicle%20docking')
25. AnnotationURLCitation(end_index=7851, start_index=7673, title='A Novel Rab9 Effector Required for Endosome-to-TGN Transport - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2138197/#:~:text=identify%20proteins%20that%20interact%20preferentially,in%20that%20the%20pure%2C%20recombinant')
26. AnnotationURLCitation(end_index=8363, start_index=8186, title='A Novel Rab9 Effector Required for Endosome-to-TGN Transport - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2138197/#:~:text=roughly%20fourfold%20preference%20to%20Rab9%E2%80%93GDP,confirmed%20by%20the%20finding%20that')
27. AnnotationURLCitation(end_index=8877, start_index=8716, title='Nde1 is a Rab9 effector for loading late endosomes to cytoplasmic dynein motor complex - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/34793709/#:~:text=retrograde%20transport%20remains%20unclear,retrograde%20transport%20to%20the%20TGN')
28. AnnotationURLCitation(end_index=9184, start_index=9023, title='Nde1 is a Rab9 effector for loading late endosomes to cytoplasmic dynein motor complex - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/34793709/#:~:text=retrograde%20transport%20remains%20unclear,retrograde%20transport%20to%20the%20TGN')
29. AnnotationURLCitation(end_index=9457, start_index=9300, title='Nde1 is a Rab9 effector for loading late endosomes to cytoplasmic dynein motor complex - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/34793709/#:~:text=interact%20with%20the%20dynein%20motor,retrograde%20transport%20to%20the%20TGN')
30. AnnotationURLCitation(end_index=9909, start_index=9780, title='Ras-related protein Rab-9A | DrugBank Online', type='url_citation', url='https://go.drugbank.com/polypeptides/P51151#:~:text=uses%20NDE1%2FNDEL1%20as%20an%20effector,By%20similarity')
31. AnnotationURLCitation(end_index=10240, start_index=10069, title='Rab9A is required for delivery of cargo from recycling endosomes to melanosomes - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4690521/#:~:text=regulate%20these%20trafficking%20steps%2C%20the,targeted%20the%20SNARE%20to%20lysosomes')
32. AnnotationURLCitation(end_index=10377, start_index=10241, title='Rab9A is required for delivery of cargo from recycling endosomes to melanosomes - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4690521/#:~:text=Rab9A,cargo%20delivery%20to%20maturing%20melanosomes')
33. AnnotationURLCitation(end_index=10887, start_index=10751, title='Rab9A is required for delivery of cargo from recycling endosomes to melanosomes - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4690521/#:~:text=knockdown%20in%20melanocytes%20results%20in,mediated')
34. AnnotationURLCitation(end_index=11196, start_index=11080, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=share%2087%C2%A0,Golgi%20network')
35. AnnotationURLCitation(end_index=11679, start_index=11540, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=In%20addition%2C%20Rab9,is%20unclear%20how%20Rab7%20and')
36. AnnotationURLCitation(end_index=11851, start_index=11680, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=Rab9%20are%20differentiated%20and%20recovered%2C,to%20the%20development%20of%20multiple')
37. AnnotationURLCitation(end_index=12169, start_index=12017, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=match%20at%20L339%20In%20addition%2C,is%20unclear%20how%20Rab7%20and')
38. AnnotationURLCitation(end_index=12591, start_index=12457, title='TMEM9 activates Rab9-dependent alternative autophagy through interaction with Beclin1 - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/39078420/#:~:text=identified,that%20multiple%20glycosylation%20of%20TMEM9')
39. AnnotationURLCitation(end_index=12715, start_index=12592, title='TMEM9 activates Rab9-dependent alternative autophagy through interaction with Beclin1 - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/39078420/#:~:text=autophagy,the%20Beclin1%20complex%20at%20the')
40. AnnotationURLCitation(end_index=13033, start_index=12899, title='TMEM9 activates Rab9-dependent alternative autophagy through interaction with Beclin1 - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/39078420/#:~:text=identified,that%20multiple%20glycosylation%20of%20TMEM9')
41. AnnotationURLCitation(end_index=13176, start_index=13034, title='TMEM9 activates Rab9-dependent alternative autophagy through interaction with Beclin1 - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/39078420/#:~:text=autophagy,autophagosome%20to%20induce%20alternative%20autophagy')
42. AnnotationURLCitation(end_index=13970, start_index=13803, title='Noncanonical Rab9a action supports retromer-mediated endosomal exit of human papillomavirus during virus entry - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10519607/#:~:text=Rab%20GTPases%20play%20key%20roles,HPV%20displays%20increased%20association%20with')
43. AnnotationURLCitation(end_index=14141, start_index=13971, title='Noncanonical Rab9a action supports retromer-mediated endosomal exit of human papillomavirus during virus entry - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10519607/#:~:text=Surprisingly%2C%20excess%20GTP,distinct%20ways%20during%20intracellular%20trafficking')
44. AnnotationURLCitation(end_index=14464, start_index=14297, title='Noncanonical Rab9a action supports retromer-mediated endosomal exit of human papillomavirus during virus entry - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10519607/#:~:text=Rab%20GTPases%20play%20key%20roles,HPV%20displays%20increased%20association%20with')
45. AnnotationURLCitation(end_index=14710, start_index=14619, title='Noncanonical Rab9a action supports retromer-mediated endosomal exit of human papillomavirus during virus entry - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10519607/#:~:text=,Rab9a')
46. AnnotationURLCitation(end_index=14881, start_index=14711, title='Noncanonical Rab9a action supports retromer-mediated endosomal exit of human papillomavirus during virus entry - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10519607/#:~:text=Surprisingly%2C%20excess%20GTP,distinct%20ways%20during%20intracellular%20trafficking')
47. AnnotationURLCitation(end_index=15197, start_index=15060, title='Noncanonical Rab9a action supports retromer-mediated endosomal exit of human papillomavirus during virus entry - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10519607/#:~:text=the%20HPV,utilize%20the%20Rab9a%20host%20trafficking')
48. AnnotationURLCitation(end_index=16113, start_index=15952, title='Nde1 is a Rab9 effector for loading late endosomes to cytoplasmic dynein motor complex - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/34793709/#:~:text=retrograde%20transport%20remains%20unclear,retrograde%20transport%20to%20the%20TGN')
49. AnnotationURLCitation(end_index=16429, start_index=16272, title='Nde1 is a Rab9 effector for loading late endosomes to cytoplasmic dynein motor complex - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/34793709/#:~:text=interact%20with%20the%20dynein%20motor,retrograde%20transport%20to%20the%20TGN')
50. AnnotationURLCitation(end_index=16726, start_index=16565, title='Nde1 is a Rab9 effector for loading late endosomes to cytoplasmic dynein motor complex - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/34793709/#:~:text=retrograde%20transport%20remains%20unclear,retrograde%20transport%20to%20the%20TGN')
51. AnnotationURLCitation(end_index=17330, start_index=17196, title='TMEM9 activates Rab9-dependent alternative autophagy through interaction with Beclin1 - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/39078420/#:~:text=identified,that%20multiple%20glycosylation%20of%20TMEM9')
52. AnnotationURLCitation(end_index=17609, start_index=17445, title='The Role of the Beclin1 Complex in Rab9-Dependent Alternative Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12470620/#:~:text=in%20canonical%20autophagy%20and%20highlight,a%20central%20scaffold%20in%20both')
53. AnnotationURLCitation(end_index=18798, start_index=18640, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=Rab%20proteins%20and%20their%20effectors,for%20HIV%20assembly%20and%20that')
54. AnnotationURLCitation(end_index=18987, start_index=18799, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=insertional%20mutagenesis%2C%20we%20identified%20Rab9%2C,replication%2C%20previous%20reports%20suggested')
55. AnnotationURLCitation(end_index=19368, start_index=19210, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=Rab%20proteins%20and%20their%20effectors,for%20HIV%20assembly%20and%20that')
56. AnnotationURLCitation(end_index=19895, start_index=19725, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=siRNA%20showed%20the%20strongest%20effect,irrelevant%20siRNA%20control%20against%20GFP')
57. AnnotationURLCitation(end_index=20049, start_index=19896, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=expression%20by%20%E2%88%BC80%20to%2090,to%20a%20lesser%20degree%20in')
58. AnnotationURLCitation(end_index=20426, start_index=20256, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=siRNA%20showed%20the%20strongest%20effect,irrelevant%20siRNA%20control%20against%20GFP')
59. AnnotationURLCitation(end_index=20580, start_index=20427, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=expression%20by%20%E2%88%BC80%20to%2090,to%20a%20lesser%20degree%20in')
60. AnnotationURLCitation(end_index=21476, start_index=21385, title='RAB9A Plays an Oncogenic Role in Human Liver Cancer Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7210512/#:~:text=Results')
61. AnnotationURLCitation(end_index=21801, start_index=21710, title='RAB9A Plays an Oncogenic Role in Human Liver Cancer Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7210512/#:~:text=Results')
62. AnnotationURLCitation(end_index=22090, start_index=21921, title='RAB9A Plays an Oncogenic Role in Human Liver Cancer Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7210512/#:~:text=RAB9A%20promoted%20the%20proliferation%20and,signaling%20pathway%20in%20human%20liver')
63. AnnotationURLCitation(end_index=23400, start_index=23242, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=The%20mutation%20or%20dysfunction%20of,By%20interacting%20with%20the%20Rab')
64. AnnotationURLCitation(end_index=23881, start_index=23742, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=TIP47%20for%20CI,internalized%20via%20caveolae%20%20111')
65. AnnotationURLCitation(end_index=24048, start_index=23882, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=with%20Lis1%2C%20dynein%2C%20and%20dynactin,internalized%20via%20caveolae%20%20111')
66. AnnotationURLCitation(end_index=25156, start_index=25012, title='Noncanonical Rab9a action supports retromer-mediated endosomal exit of human papillomavirus during virus entry - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10519607/#:~:text=independent%20mannose,cargo%20trafficking%20in%20our%20cell')
67. AnnotationURLCitation(end_index=25475, start_index=25290, title='A Novel Rab9 Effector Required for Endosome-to-TGN Transport - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2138197/#:~:text=cofractionates%20with%20endosomes%20containing%20mannose,process%20of%20transport%20vesicle%20docking')
68. AnnotationURLCitation(end_index=26457, start_index=26325, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=NdeI%20are%20Rab9%20effectors%20,Golgi%20network')
69. AnnotationURLCitation(end_index=26565, start_index=26458, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=mannose,Golgi%20network')
70. AnnotationURLCitation(end_index=27137, start_index=27007, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=match%20at%20L330%20NdeI%20are,Golgi%20network')
71. AnnotationURLCitation(end_index=27277, start_index=27138, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=TIP47%20for%20CI,internalized%20via%20caveolae%20%20111')
72. AnnotationURLCitation(end_index=27970, start_index=27859, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=endosome%20maturation%20,23')
73. AnnotationURLCitation(end_index=28348, start_index=28177, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=In%20addition%20to%20Rab7%2C%20late,TIP47%2C%20GCC185%2C%20p40%2C%20RUTBC1%2F2%2C%20and')
74. AnnotationURLCitation(end_index=28472, start_index=28349, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=are%20required%20to%20transport%20CI,23')
75. AnnotationURLCitation(end_index=28972, start_index=28803, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=different%20mechanisms%20and%20are%20present,of%20TIP47%20to%20endosomes%20containing')
76. AnnotationURLCitation(end_index=29137, start_index=28973, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=In%20addition%20to%20Rab7%2C%20late,isoforms%2C%20Rab9A%20and%20Rab9B%2C%20which')
77. AnnotationURLCitation(end_index=29509, start_index=29347, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=match%20at%20L321%20In%20addition,isoforms%2C%20Rab9A%20and%20Rab9B%2C%20which')
78. AnnotationURLCitation(end_index=29649, start_index=29510, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=In%20addition%2C%20Rab9,is%20unclear%20how%20Rab7%20and')
79. AnnotationURLCitation(end_index=29988, start_index=29874, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=Rab9%20%20,%5B90%5D%2C%20%5B91')
80. AnnotationURLCitation(end_index=30132, start_index=29989, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=RUTBC1%20protein%2C%20a%20Rab9A%20effector,Google%20Scholar')
81. AnnotationURLCitation(end_index=30674, start_index=30507, title='Noncanonical Rab9a action supports retromer-mediated endosomal exit of human papillomavirus during virus entry - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10519607/#:~:text=Rab%20GTPases%20play%20key%20roles,HPV%20displays%20increased%20association%20with')
82. AnnotationURLCitation(end_index=30845, start_index=30675, title='Noncanonical Rab9a action supports retromer-mediated endosomal exit of human papillomavirus during virus entry - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10519607/#:~:text=Surprisingly%2C%20excess%20GTP,distinct%20ways%20during%20intracellular%20trafficking')
83. AnnotationURLCitation(end_index=31763, start_index=31628, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=Rab4%2C%20Rab5%2C%20Rab7%2C%20Rab9%2C%20Rab10%2C,93')
84. AnnotationURLCitation(end_index=32060, start_index=31889, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=from%20late%20endosomes%20to%20lysosomes,endosome%3B%20LE%3A%20late%20endosome%3B%20TGN')
85. AnnotationURLCitation(end_index=32469, start_index=32353, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=share%2087%C2%A0,Golgi%20network')
86. AnnotationURLCitation(end_index=32593, start_index=32470, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=are%20required%20to%20transport%20CI,23')
87. AnnotationURLCitation(end_index=33502, start_index=33339, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=match%20at%20L415%20siRNA%20showed,irrelevant%20siRNA%20control%20against%20GFP')
88. AnnotationURLCitation(end_index=33673, start_index=33503, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=siRNA%20showed%20the%20strongest%20effect,irrelevant%20siRNA%20control%20against%20GFP')
89. AnnotationURLCitation(end_index=33972, start_index=33819, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=expression%20by%20%E2%88%BC80%20to%2090,to%20a%20lesser%20degree%20in')
90. AnnotationURLCitation(end_index=34270, start_index=34114, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=match%20at%20L624%20measles%20virus,the%20transient%20nature%20of%20mRNA')
91. AnnotationURLCitation(end_index=34926, start_index=34741, title='A Novel Rab9 Effector Required for Endosome-to-TGN Transport - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2138197/#:~:text=cofractionates%20with%20endosomes%20containing%20mannose,process%20of%20transport%20vesicle%20docking')
92. AnnotationURLCitation(end_index=35535, start_index=35391, title='Noncanonical Rab9a action supports retromer-mediated endosomal exit of human papillomavirus during virus entry - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10519607/#:~:text=independent%20mannose,cargo%20trafficking%20in%20our%20cell')
93. AnnotationURLCitation(end_index=36109, start_index=35938, title='Rab9A is required for delivery of cargo from recycling endosomes to melanosomes - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4690521/#:~:text=regulate%20these%20trafficking%20steps%2C%20the,targeted%20the%20SNARE%20to%20lysosomes')
94. AnnotationURLCitation(end_index=36246, start_index=36110, title='Rab9A is required for delivery of cargo from recycling endosomes to melanosomes - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4690521/#:~:text=Rab9A,cargo%20delivery%20to%20maturing%20melanosomes')
95. AnnotationURLCitation(end_index=36649, start_index=36478, title='Rab9A is required for delivery of cargo from recycling endosomes to melanosomes - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4690521/#:~:text=regulate%20these%20trafficking%20steps%2C%20the,targeted%20the%20SNARE%20to%20lysosomes')
96. AnnotationURLCitation(end_index=37320, start_index=37152, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=different%20mechanisms%20and%20are%20present,Rab9A%20increases%20the%20affinity%20of')
97. AnnotationURLCitation(end_index=37537, start_index=37439, title='Ras-related protein Rab-9A | DrugBank Online', type='url_citation', url='https://go.drugbank.com/polypeptides/P51151#:~:text=Chromosome%20Location%20X')
98. AnnotationURLCitation(end_index=37856, start_index=37734, title='RAB9A protein expression summary - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000123595-RAB9A#:~:text=Atlas%20www,RNA%29Mouse%20brain%20Tau')
99. AnnotationURLCitation(end_index=38294, start_index=38132, title='Ras-related protein Rab-9A | DrugBank Online', type='url_citation', url='https://go.drugbank.com/polypeptides/P51151#:~:text=binding%20protein%20homologue%20ORP1L%20interacts,Mortensen%20P%2C%20Mann%20M%3A%20Global')
100. AnnotationURLCitation(end_index=38417, start_index=38295, title='Ras-related protein Rab-9A | DrugBank Online', type='url_citation', url='https://go.drugbank.com/polypeptides/P51151#:~:text=functional%20role%20for%20the%20GCC185,2008%20Jan')
101. AnnotationURLCitation(end_index=38814, start_index=38656, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=Rab%20proteins%20and%20their%20effectors,for%20HIV%20assembly%20and%20that')
102. AnnotationURLCitation(end_index=39003, start_index=38815, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=insertional%20mutagenesis%2C%20we%20identified%20Rab9%2C,replication%2C%20previous%20reports%20suggested')
103. AnnotationURLCitation(end_index=39425, start_index=39334, title='RAB9A Plays an Oncogenic Role in Human Liver Cancer Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7210512/#:~:text=Results')
104. AnnotationURLCitation(end_index=39796, start_index=39705, title='RAB9A Plays an Oncogenic Role in Human Liver Cancer Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7210512/#:~:text=Results')
105. AnnotationURLCitation(end_index=40485, start_index=40349, title='A Novel Rab9 Effector Required for Endosome-to-TGN Transport - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2138197/#:~:text=Rab9%20GTPase%20is%20required%20for,associated%20p40')
106. AnnotationURLCitation(end_index=40652, start_index=40520, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=NdeI%20are%20Rab9%20effectors%20,Golgi%20network')
107. AnnotationURLCitation(end_index=40830, start_index=40711, title='Ras-related protein Rab-9A | DrugBank Online', type='url_citation', url='https://go.drugbank.com/polypeptides/P51151#:~:text=fusion%20%28By%20similarity%29,By%20similarity')
108. AnnotationURLCitation(end_index=41034, start_index=40876, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=Rab%20proteins%20and%20their%20effectors,for%20HIV%20assembly%20and%20that')
109. AnnotationURLCitation(end_index=41263, start_index=41092, title='Rab9A is required for delivery of cargo from recycling endosomes to melanosomes - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4690521/#:~:text=regulate%20these%20trafficking%20steps%2C%20the,targeted%20the%20SNARE%20to%20lysosomes')
110. AnnotationURLCitation(end_index=41471, start_index=41304, title='Noncanonical Rab9a action supports retromer-mediated endosomal exit of human papillomavirus during virus entry - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10519607/#:~:text=Rab%20GTPases%20play%20key%20roles,HPV%20displays%20increased%20association%20with')
111. AnnotationURLCitation(end_index=41679, start_index=41518, title='Nde1 is a Rab9 effector for loading late endosomes to cytoplasmic dynein motor complex - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/34793709/#:~:text=retrograde%20transport%20remains%20unclear,retrograde%20transport%20to%20the%20TGN')
112. AnnotationURLCitation(end_index=41951, start_index=41782, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=different%20mechanisms%20and%20are%20present,of%20TIP47%20to%20endosomes%20containing')
113. AnnotationURLCitation(end_index=42091, start_index=41952, title='Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9418685/#:~:text=TIP47%20for%20CI,internalized%20via%20caveolae%20%20111')